Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Ramps Up Its Biosimilars Business

06 Aug 2010

• By Wendy Diller

Strategy includes launching 10 monoclonal antibodies by 2016 at the earliest

Related Content

Pfizer Bulks Up Its Generics Business

03 Mar 2009

Pfizer Increases Commitment To Rare Diseases With New Research Unit

21 Jun 2010

Merck Prepares To Test Drive Biosimilar Pathway In The U.S.

05 Jul 2010

Pfizer Thinks Small: Partnership With Protalix On Gaucher Drug Eyes Cheaper Plant-Based Production

07 Dec 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.